Cytovale | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated...
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Their FDA cleared IntelliSep test analyzes white blood cells to stratify a patient’s risk of sepsis in under 10 minutes, addressing the urgent need for early detection of this lethal condition.
Website
Headquarters
San Francisco, CA
Size
51-200 employees
Industry
Biotechnology Research
Specialities
medical device
🛍️ Cytovale Product and Pricing News →
👔 Cytovale CEO, Management and Leadership Team →
⚔️ Cytovale Alternatives and Competitors →
💼 Cytovale Hiring and Layoffs →
🤖 Cytovale Developer, Integration and Automation News →
📈 Cytovale Financials, Fundraising and Valuation News →
🛍️ Cytovale Product and Pricing News
- Cytovale's IntelliSep is the first and only FDA-cleared cellular host diagnostic for use in the emergency department.
- Cytovale's rapid lab test for sepsis, IntelliSep, has been cleared by the US FDA and reported to reduce sepsis mortality by over 30%.
- Cytovale CEO Ajay Shah will speak about innovation in early sepsis detection at the 13th Annual Forbes Healthcare Summit on December 4, 2024, in New York.
- Cytovale won Inc. Magazine’s 2024 Best In Business award in the Health Products category.
- Cytovale won the 'Biggest Healthcare Savings Story' award at the DigiHlthHubFdn Awards 2024 for reducing healthcare costs.
- Cytovale will showcase their IntelliSep sepsis test at CHEST2024, Booth 1252.
- Cytovale's IntelliSep test showed a 98% negative predictive value for sepsis in a study of over 1,000 adult emergency department patients.
👔 Cytovale CEO, Management and Leadership Team
-
Chief Financial Officer
[email protected] -
Executive Vice President of People[email protected]
-
Executive Vice President Commercial Strategy[email protected]
-
CTO, Cytovale[email protected]
⚔️ Cytovale Alternatives and Competitors
- Immunexpress |
- Qvella |
- Inflammatix |
- OpGen |
- SphingoTec |
- HandyLab |
- Avails Medical |
- Resistell |
- Cynvenio Biosystems |
- Owl biomedical |
- NanoCellect Biomedical |
- Sirigen |
- Gravity Diagnostics |
- Redcliffe Labs |
- Rapture Biotech |
- Infervision |
- Genuity Science |
- Utilidata |
- DiaCarta |
- Mission Bio |
- Quadrants Scientific
💼 Cytovale Hiring and Layoffs
- Chris Fong, MBA has joined Cytovale as Vice President of Commercial Excellence, previously serving as Senior Director, US Marketing, Rare Disease, Thought Leader Liaison Lead, TTR Franchise at Alnylam Pharmaceuticals.
- Robert Kreiner has joined Cytovale as a Business Development Executive in the United States, previously serving as Director of Medication Management at BD.
- Jessica Taylor has joined Cytovale as a Senior Clinical Consultant in the United States, previously working as an Emergency Nurse at Endeavor Health.
- Ajay Shah, Ph.D., is the Cofounder & Chief Executive Officer of Cytovale.
- Cytovale is hiring for positions to enhance sepsis detection and patient care.
- Analynne Madrid has been promoted to Senior Manufacturing Engineer at Cytovale.
- Hannah Tarling has joined Cytovale as Customer Service and Commercial Order Lead in the United States, previously serving as Sr. Customer Service Operations Specialist at Outset Medical, Inc.
- Jeff Smith has left Cytovale, where he served as Sr Manager, Consumables R&D in the United States, to join Overture Life as Associate Director of Engineering.
🤖 Cytovale Developer, Integration and Automation News
- Our Lady of the Lake Ascension in Louisiana chose Cytovale to support faster sepsis detection.
📈 Cytovale Financials, Fundraising and Valuation News
- Cytovale has acquired Sepsis Scout, a company using wearable technology and AI to predict and prevent sepsis outside of hospitals.
- Cytovale's $100M Series D funding was highlighted on the Nasdaq Tower in Times Square.
- Cytovale, co-founded by UCLA's Dino Di Carlo and Henry Tse, has raised $100M for the hospital rollout of its FDA-cleared early sepsis-detection tool IntelliSep.
- Wilson Sonsini, led by Matt Bresnahan, advised Cytovale on IP matters for their $100 million Series D financing.
- Dr. Stopyra receives research funding from Cytovale and several other organizations.
People also viewed
- Medtronic |
- Robeauté |
- Starship Technologies |
- Sunrise Robotics |
- Molyon |
- Helsing |
- Liferaft |
- Teton |
- Hubble |
- Mos
